Portside Wealth Group LLC Has $5.63 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Portside Wealth Group LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 9,630 shares of the healthcare conglomerate’s stock after buying an additional 285 shares during the period. UnitedHealth Group makes up approximately 1.0% of Portside Wealth Group LLC’s investment portfolio, making the stock its 23rd largest position. Portside Wealth Group LLC’s holdings in UnitedHealth Group were worth $5,630,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in UnitedHealth Group by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after purchasing an additional 544,740 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after purchasing an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp increased its position in UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after purchasing an additional 35,533 shares during the last quarter. International Assets Investment Management LLC boosted its stake in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent analyst reports. UBS Group decreased their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. KeyCorp initiated coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 target price for the company. Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Morgan Stanley cut their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, Barclays dropped their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $605.45 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The firm has a market capitalization of $557.18 billion, a price-to-earnings ratio of 39.44, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average of $581.13 and a 200-day moving average of $543.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the previous year, the business earned $6.56 EPS. The firm’s revenue was up 9.2% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.